Report

Medical Nutrition Terminology and Regulations in the United States and Europe
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA
Economic Analysis of Vaccination Programs - Good Practices for Outcomes Research Task Force Report
Application of Constrained Optimization Methods in Health Services Research
Challenges in Research and Health Technology Assessment of Rare Disease Technologies:
A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report 1
A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report 7
Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report 4
Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report 5
Review of Recent US Value Frameworks—A Health Economics Approach: An ISPOR Special Task Force Report 6
An Overview of Value, Perspective, and Decision Context—A Health Economics Approach: An ISPOR Special Task Force Report 2
Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report 3
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness
Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0
Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials
Constrained Optimization Methods in Health Services Research-An Introduction
Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures
Clinician-Reported Outcome Assessments of Treatment Benefit-Clinical Outcome Assessment Emerging Good Practices Task Force
Estimating Health-State Utility for Economic Models in Clinical Studies
Statistical Methods for the Analysis of Discrete-Choice Experiments

1
2
3 (current)
4
5
6
7

Questions?

For any questions about this report please contact us.

Report

Medical Nutrition Terminology and Regulations in the United States and Europe

Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA

Economic Analysis of Vaccination Programs - Good Practices for Outcomes Research Task Force Report

Application of Constrained Optimization Methods in Health Services Research

Challenges in Research and Health Technology Assessment of Rare Disease Technologies:

A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report 1

A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report 7

Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report 4

Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report 5

Review of Recent US Value Frameworks—A Health Economics Approach: An ISPOR Special Task Force Report 6

An Overview of Value, Perspective, and Decision Context—A Health Economics Approach: An ISPOR Special Task Force Report 2

Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report 3

Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials

Constrained Optimization Methods in Health Services Research-An Introduction

Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures

Clinician-Reported Outcome Assessments of Treatment Benefit-Clinical Outcome Assessment Emerging Good Practices Task Force

Estimating Health-State Utility for Economic Models in Clinical Studies

Statistical Methods for the Analysis of Discrete-Choice Experiments

Questions?

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Your browser is out-of-date